Abstract Body

Defective HIV proviruses within a few specific genes have been associated with T cell clonal expansion and persistence during ART. Recently, proviruses integrated in STAT3 and LCK have been implicated in insertional mutagenesis driving rare cases of T cell lymphoma. However, B cell lymphomas are much more common HIV–associated cancers, and a case report by Katano et al. identified an HIV provirus within STAT3 in a B cell lymphoma in an individual with AIDS. HIV is not typically characterized as infecting B cells, but HIV positive individuals are at a great risk of developing non-Hodgkin’s lymphomas of B cell origin despite being on ART. We hypothesize that site-specific HIV proviral integrations can lead to B cell transformation and may be a contributing cause to HIV-associated B cell lymphomas.

Whole genome amplified DNA samples extracted from formalin-fixed paraffin embedded HIV-associated B cell lymphoma samples were obtained from the AIDS and Cancer Specimen Resource and assessed for HIV provirus content by PCR targeting the U5 region of the LTR. Proviruses were quantified relative to CCR5, a human reference gene. Integration site analysis was performed on two DNA samples that showed significant quantities of HIV LTR per cell (Figure 1).

Our screen identified 2 out 110 samples to be highly positive (between 0.3-5.0 copies/cell) for HIV proviruses, with many more containing significant, but lower, proviral DNA levels. The two highly positive samples were subjected to integration site analysis for detection characterization of the location of clonal proviruses. Both samples contained many uniquely detected integration sites. A clonal population was identified within at least one B cell lymphoma-associated gene, SGK1, but it comprised only a small percentage (1.2%) of total integration sites detected.

We have demonstrated the presence of high-levels of HIV provirus within a small fraction of HIV-associated B cell lymphoma. Although further studies will be required to confirm the precise cell type that contains them, B cells can be targets for HIV infection based on prior in vitro studies. HIV-driven B cell lymphoma may still be a possibility with detection of HIV integration within SGK1, a gene whose product associates with the STAT3 protein, found in a small percentage of one sample. Further work needs to be done to determine to what extent B cells become infected with HIV and to what extent its integration can lead to B cell lymphoma development.